- Advertisement -

Researchers assess the evolution and diversity of monkeypox virus genomes using phylogenomic analysis

In a recent study published in Travel Medicine and Infectious Disease, researchers phylogenomically analyzed the monkeypox virus (MPXV). Study: Phylogenomic analysis of the monkeypox...

Product Innovation and Technological Advancements to Aid the Growth of the Biotechnology Market 2017 – 2025 – Hitz Dairies

TMRR, in its fresh marketplace document, means that the Biotechnology marketplace document is ready to exceed US$ xx Mn/Bn through 2029. The...

What explains our lower back pain? Anthropologists turn to Neandertals for answers

Examining the spines of Neandertals, an extinct human relative, may explain back-related ailments experienced by humans today, a team of anthropologists has concluded in...

Identifying compound classes through machine learning

Bioinformaticians at the University of Jena and partners develop new method for analysing metabolites Credit: Image: Jens Meyer/University of Jena

Gilead to Acquire Forty Seven for $4.9B, Expanding Immuno-Oncology Pipeline

Daniel O’Day, Gilead Sciences Chairman and CEO Gilead Sciences has agreed to acquire Forty Seven for $4.9 billion cash, the companies said today, in a...

Antibiotic innovation helps fight against superbugs

RMIT scientists have created a new type of antibiotic that can be rapidly re-engineered to avoid resistance by dangerous superbugs. Credit: RMIT University RMIT scientists have...

AI Drug Developer Xaira Therapeutics Launches with $1B+

Marc Tessier-Lavigne, PhD, Xaira Therapeutics founding CEO, and Bing presidential professor, head of laboratory at Stanford University AI-based drug developer Xaira Therapeutics has been launched...

Ludwig Lausanne scientists identify and show how to target a key...

April 24, 2024, NEW YORK – A Ludwig Cancer Research study has discovered how a lipid molecule found at high levels within tumors undermines...

AI Drug Developer Xaira Therapeutics Launches with $1B+

Marc Tessier-Lavigne, PhD, Xaira Therapeutics founding CEO, and Bing presidential professor, head of laboratory at Stanford University AI-based drug developer Xaira Therapeutics has been launched...

Ludwig Lausanne scientists identify and show how to target a key tumor defense against...

April 24, 2024, NEW YORK – A Ludwig Cancer Research study has discovered how a lipid molecule found at high levels within tumors undermines...

Accelerating Research with Configurable Workflow, AI Assistants and FAIR Data

REGISTER NOW Broadcast Date:  Wednesday, April 24, 2024Time:  8:00 am PDT, 11:00 am EDT, 17:00 CEST Workflow design and data management are pivotal components...

more new items

AI Drug Developer Xaira Therapeutics Launches with $1B+

Marc Tessier-Lavigne, PhD, Xaira Therapeutics founding CEO, and Bing presidential professor, head of laboratory at Stanford University AI-based drug developer Xaira Therapeutics has been launched...

Ludwig Lausanne scientists identify and show how to target a key...

April 24, 2024, NEW YORK – A Ludwig Cancer Research study has discovered how a lipid molecule found at high levels within tumors undermines...

Accelerating Research with Configurable Workflow, AI Assistants and FAIR Data

REGISTER NOW Broadcast Date:  Wednesday, April 24, 2024Time:  8:00 am PDT, 11:00 am EDT, 17:00 CEST Workflow design and data management are pivotal components...